_id

690f3d61ccc777a4e85d1aa3

Ticker

CELC

Name

Celcuity LLC

Exchange

NASDAQ

Address

16305 36th Avenue North, Minneapolis, MN, United States, 55446

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.celcuity.com

Description

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). It also engages in developing of CELsignia diagnostic platform. The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is based in Minneapolis, Minnesota.

Last Close

105.25

Volume

181552

Current Price

102.18

Change

-2.9168646080760032

Last Updated

2025-11-29T11:18:53.384Z

Image

data:image/webp;base64,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

Ipo Date

2017-09-20T00:00:00.000Z

Market Cap

4679875072

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.3268666666666667

Sentiment Sources

15

Rating

4.7143

Target Price

103.5556

Strong Buy

5

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

154000

Cost Of Revenue

77000

Gross Profit

77000

Operating Expenses

42849000

Operating Income

-42849000

Interest Expense

17369000

Pretax Income

-43804000

Net Income

-43804000

Eps

-0.978090190258236

Dividends Per Share

-

Shares Outstanding

46271259

Income Tax Expense

-

EBITDA

-26394000

Operating Margin

-27824.02597402597

Total Other Income Expense Net

-955000

Cash

74252000

Short Term Investments

380726000

Receivables

-

Inventories

-

Total Current Assets

475497000

Property Plant Equipment

507000

Total Assets

476004000

Payables

11418000

Short Term Debt

96000

Long Term Debt

320249000

Total Liabilities

359041000

Equity

116963000

Depreciation

41000

Change In Working Capital

-7699000

Cash From Operations

-44816000

Capital Expenditures

97000

Cash From Investing

-257611000

Cash From Financing

330325000

Net Change In Cash

27898000

PE

-

PB

40.30031795525081

ROE

-37.451159768473794

ROA

-9.202443676943892

FCF

-44913000

Fcf Percent

-291.64285714285717

Piotroski FScore

0

Health Score

8

Deep Value Investing Score

2

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.3

Garp Investing Score

0.5

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

1

Quality Investing Score

1.5

Value Investing Score

2

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

154000

Quarters > 0 > income Statement > cost Of Revenue

77000

Quarters > 0 > income Statement > gross Profit

77000

Quarters > 0 > income Statement > operating Expenses

42849000

Quarters > 0 > income Statement > operating Income

-42849000

Quarters > 0 > income Statement > interest Expense

17369000

Quarters > 0 > income Statement > pretax Income

-43804000

Quarters > 0 > income Statement > net Income

-43804000

Quarters > 0 > income Statement > eps

-0.978090190258236

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

44785236

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-26394000

Quarters > 0 > income Statement > operating Margin

-27824.02597402597

Quarters > 0 > income Statement > total Other Income Expense Net

-955000

Quarters > 0 > balance Sheet > cash

74252000

Quarters > 0 > balance Sheet > short Term Investments

380726000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

475497000

Quarters > 0 > balance Sheet > property Plant Equipment

507000

Quarters > 0 > balance Sheet > total Assets

476004000

Quarters > 0 > balance Sheet > payables

11418000

Quarters > 0 > balance Sheet > short Term Debt

96000

Quarters > 0 > balance Sheet > long Term Debt

320249000

Quarters > 0 > balance Sheet > total Liabilities

359041000

Quarters > 0 > balance Sheet > equity

116963000

Quarters > 0 > cash Flow > net Income

-43804000

Quarters > 0 > cash Flow > depreciation

41000

Quarters > 0 > cash Flow > change In Working Capital

-7699000

Quarters > 0 > cash Flow > cash From Operations

-44816000

Quarters > 0 > cash Flow > capital Expenditures

97000

Quarters > 0 > cash Flow > cash From Investing

-257611000

Quarters > 0 > cash Flow > cash From Financing

330325000

Quarters > 0 > cash Flow > net Change In Cash

27898000

Quarters > 0 > ratios > PE

-0.978090190258236

Quarters > 0 > ratios > PB

40.30031795525081

Quarters > 0 > ratios > ROE

-37.451159768473794

Quarters > 0 > ratios > ROA

-9.202443676943892

Quarters > 0 > ratios > FCF

-44913000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-291.64285714285717

Quarters > 0 > health Score

8

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

40000

Quarters > 1 > income Statement > gross Profit

-40000

Quarters > 1 > income Statement > operating Expenses

44009000

Quarters > 1 > income Statement > operating Income

-44009000

Quarters > 1 > income Statement > interest Expense

3204000

Quarters > 1 > income Statement > pretax Income

-45268000

Quarters > 1 > income Statement > net Income

-45268000

Quarters > 1 > income Statement > eps

-1.0367501688600997

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

43663364

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-42024000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-1259000

Quarters > 1 > balance Sheet > cash

46354000

Quarters > 1 > balance Sheet > short Term Investments

122032000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

183104000

Quarters > 1 > balance Sheet > property Plant Equipment

488000

Quarters > 1 > balance Sheet > total Assets

183592000

Quarters > 1 > balance Sheet > payables

11158000

Quarters > 1 > balance Sheet > short Term Debt

139000

Quarters > 1 > balance Sheet > long Term Debt

99276000

Quarters > 1 > balance Sheet > total Liabilities

139217000

Quarters > 1 > balance Sheet > equity

44375000

Quarters > 1 > cash Flow > net Income

-45268000

Quarters > 1 > cash Flow > depreciation

40000

Quarters > 1 > cash Flow > change In Working Capital

4238000

Quarters > 1 > cash Flow > cash From Operations

-36212000

Quarters > 1 > cash Flow > capital Expenditures

39000

Quarters > 1 > cash Flow > cash From Investing

65856000

Quarters > 1 > cash Flow > cash From Financing

232000

Quarters > 1 > cash Flow > net Change In Cash

29876000

Quarters > 1 > ratios > PE

-1.0367501688600997

Quarters > 1 > ratios > PB

103.56211968450705

Quarters > 1 > ratios > ROE

-102.01239436619719

Quarters > 1 > ratios > ROA

-24.656847792932155

Quarters > 1 > ratios > FCF

-36251000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

17

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

37000

Quarters > 2 > income Statement > gross Profit

-37000

Quarters > 2 > income Statement > operating Expenses

36133000

Quarters > 2 > income Statement > operating Income

-36133000

Quarters > 2 > income Statement > interest Expense

3183000

Quarters > 2 > income Statement > pretax Income

-36997000

Quarters > 2 > income Statement > net Income

-36997000

Quarters > 2 > income Statement > eps

-0.859341017347623

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

43052757

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-33777000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-864000

Quarters > 2 > balance Sheet > cash

16478000

Quarters > 2 > balance Sheet > short Term Investments

189213000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

217597000

Quarters > 2 > balance Sheet > property Plant Equipment

530000

Quarters > 2 > balance Sheet > total Assets

218127000

Quarters > 2 > balance Sheet > payables

9932000

Quarters > 2 > balance Sheet > short Term Debt

169000

Quarters > 2 > balance Sheet > long Term Debt

98527000

Quarters > 2 > balance Sheet > total Liabilities

131459000

Quarters > 2 > balance Sheet > equity

86668000

Quarters > 2 > cash Flow > net Income

-36997000

Quarters > 2 > cash Flow > depreciation

37000

Quarters > 2 > cash Flow > change In Working Capital

-1190000

Quarters > 2 > cash Flow > cash From Operations

-35853000

Quarters > 2 > cash Flow > capital Expenditures

60000

Quarters > 2 > cash Flow > cash From Investing

24262000

Quarters > 2 > cash Flow > cash From Financing

5554000

Quarters > 2 > cash Flow > net Change In Cash

-6036823

Quarters > 2 > ratios > PE

-0.859341017347623

Quarters > 2 > ratios > PB

52.28345726508054

Quarters > 2 > ratios > ROE

-42.68818941247058

Quarters > 2 > ratios > ROA

-16.961219839818085

Quarters > 2 > ratios > FCF

-35913000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

25

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

121344

Quarters > 3 > income Statement > cost Of Revenue

35254

Quarters > 3 > income Statement > gross Profit

-35254

Quarters > 3 > income Statement > operating Expenses

36394877

Quarters > 3 > income Statement > operating Income

-36430131

Quarters > 3 > income Statement > interest Expense

3275161

Quarters > 3 > income Statement > pretax Income

-36653041

Quarters > 3 > income Statement > net Income

-36653041

Quarters > 3 > income Statement > eps

-0.8549026781633801

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

42873934

Quarters > 3 > income Statement > income Tax Expense

-3

Quarters > 3 > income Statement > EBITDA

-33342626

Quarters > 3 > income Statement > operating Margin

-30022.193928006327

Quarters > 3 > income Statement > total Other Income Expense Net

-222910

Quarters > 3 > balance Sheet > cash

22514823

Quarters > 3 > balance Sheet > short Term Investments

212588960

Quarters > 3 > balance Sheet > receivables

1600621

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

244571030

Quarters > 3 > balance Sheet > property Plant Equipment

552017

Quarters > 3 > balance Sheet > total Assets

245123047

Quarters > 3 > balance Sheet > payables

9366007

Quarters > 3 > balance Sheet > short Term Debt

171952

Quarters > 3 > balance Sheet > long Term Debt

97727136

Quarters > 3 > balance Sheet > total Liabilities

129504012

Quarters > 3 > balance Sheet > equity

115619035

Quarters > 3 > cash Flow > net Income

-36653041

Quarters > 3 > cash Flow > depreciation

35254

Quarters > 3 > cash Flow > change In Working Capital

4467220

Quarters > 3 > cash Flow > cash From Operations

-27769983

Quarters > 3 > cash Flow > capital Expenditures

45149

Quarters > 3 > cash Flow > cash From Investing

37558517

Quarters > 3 > cash Flow > cash From Financing

123000

Quarters > 3 > cash Flow > net Change In Cash

9911534

Quarters > 3 > ratios > PE

-0.8549026781633801

Quarters > 3 > ratios > PB

39.02888095805332

Quarters > 3 > ratios > ROE

-31.70156280927271

Quarters > 3 > ratios > ROA

-14.95291505575973

Quarters > 3 > ratios > FCF

-27815132

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-229.22544171940928

Quarters > 3 > health Score

17

Valuation > metrics > PE

-0.978090190258236

Valuation > metrics > PB

40.30031795525081

Valuation > final Score

20

Valuation > verdict

1243.3% Overvalued

Profitability > metrics > ROE

-37.451159768473794

Profitability > metrics > ROA

-9.212255808133385

Profitability > metrics > Net Margin

-284.4415584415584

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

3.0696972546873798

Risk > metrics > Interest Coverage

-2.4669814036501814

Risk > final Score

-4

Risk > verdict

High

Liquidity > metrics > Current Ratio

41.29729025534132

Liquidity > metrics > Quick Ratio

41.29729025534132

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-49

Prev Risks > 1

-15

Prev Risks > 2

-14

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T12:59:16.410Z